About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
About Us
Our Mission & Values
Leadership Team
Board of Directors
Partners
Corporate Giving
Responsibility
Press Releases
Medicines
Science
Clinical Trials
Publications
Treatment Access
Patients & Caregivers
Our Commitment to Patients
Patient Voices
CKD with Hyperphosphatemia
IBS-C
Join Us
Working at Ardelyx
Benefits
Open Positions
Medical Professionals
Investors & Media
Publications
Disease Area
Hyperphosphatemia
IBS-C
Year
All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Filter
2024
Intestinal Permeability, Irritable Bowel Syndrome with Constipation, and the Role of Sodium-Hydrogen Exchanger Isoform 3 (NHE3)
Clinical and Experimental Gastroenterology
Tenapanor: A Phosphate Absorption Inhibitor for the Management of Hyperphosphatemia in Patients with Kidney Failure
Journal of Renal Nutrition
Tenapanor Effectiveness for Treating Hyperphosphatemia in Patients Receiving Maintenance Dialysis: a Plain Language Summary of the OPTIMIZE Study
Current Medical Research and Opinion
Tenapanor Improves Long-term Control of High Phosphate Concentrations in the Blood in Patients Receiving Maintenance Dialysis: a Plain Language Summary of the NORMALIZE Study
Current Medical Research and Opinion
Long-Term Safety of Tenapanor in Patients with Irritable Bowel Syndrome with Constipation in the T3MPO-3 Study: Plain Language Summary of the Publication
Therapeutic Advances in Gastroenterology
Pages:
1
2
3
4
5
6
7
8
Load More
Sorry, nothing found in this query